CYTRX
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Feb 2023)
What this means for you
This application is over — abandoned 20 Feb 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90309669
- Mark type
- Stylized text
- Filed
- 10 Nov 2020
- Published for opposition
- 25 May 2021
- Abandoned
- 20 Feb 2023
- Attorney of record
- Emilia F. Cannella
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cancer
Owner
- CytRx Corporation, Los Angeles, CA, US
- CytRx Corporation, Los Angeles, CA, US
Prosecution history
- 21 Feb 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Feb 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 13 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jul 2022 — SOU EXTENSION 2 GRANTED
- 11 Jul 2022 — SOU EXTENSION 2 FILED
- 11 Jul 2022 — SOU TEAS EXTENSION RECEIVED
- 22 Jan 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jan 2022 — SOU EXTENSION 1 GRANTED
- 20 Jan 2022 — SOU EXTENSION 1 FILED
- 20 Jan 2022 — SOU TEAS EXTENSION RECEIVED
- 20 Jul 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 May 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 May 2021 — PUBLISHED FOR OPPOSITION
- 05 May 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Apr 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER